|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Laparoscopic natural orifice specimen extraction-colectomy: A systematic review显示文摘Over the last 20 years, laparoscopic colorectal surgery has shown equal efficacy for benign and malignant colorectal diseases when compared to open surgery. However, a laparoscopic approach reduces postoperative morbidity and shortens hospital stay. In the quest to optimize outcomes after laparoscopic colorectal surgery, reduction of access trauma could be a way to improve recovery. To date, one method to reduce access trauma is natural orifice specimen extraction(NOSE). NOSE aims to reduce access trauma in laparoscopic colorectal surgery. The specimen is delivered via a natural orifice and the anastomosis is created intracorporeally. Different methods are used to extract the specimen and to create a bowel anastomosis. Currently, specimens are delivered transcolonically, transrectally, transanally, or transvaginally. Each of these NOSEprocedures raises specific issues with regard to operative technique and application. The presumed benefits of NOSE-procedures are less pain, lower analgesia requirements, faster recovery, shorter hospital stay, better cosmetic results, and lower incisional hernia rates. Avoidance of extraction site laparotomy is the most important characteristic of NOSE. Concerns associated with the NOSE-technique include bacterial contamination of the peritoneal cavity, inflammatory response, and postoperative outcomes, including postoperative pain and the functional and oncologic outcomes. These issues need to be studied in prospective randomized controlled trials. The aim of this systematic review is to describe the role of NOSE in minimally invasive colorectal surgery. | Albert M Wolthuis Anthony de Buck van Overstraeten André D'Hoore | 2014 | World Journal of Gastroenterology2014，20，36： | 65 |
| 2 | Transanal total mesorectal excision:Towards standardization of technique显示文摘AIM: To describe the role of Transanal total mesorectal excision(Ta TME) in minimally invasive rectal cancer surgery, to examine the differences in patient selection and in reported surgical techniques and their impactson postoperative outcomes and to discuss the future of Ta TME. METHODS: MEDLINE(Pub Med), EMBASE, and The Cochrane Library were systematically searched through the 1st of March 2015 using a predefined search strategy. RESULTS: A total of 20 studies with 323 patients were included. Most studies were single-arm prospective studies with fewer than 100 patients. Multiple transanal access platforms were used, and the laparoscopic approach was either multi- or single port. The procedure was initiated transanally or transabdominally. If a simultaneous approach with 2 operating surgeons was chosen, the operative time was significantly reduced. CONCLUSION: Ta TME was also associated with better TME specimens and a longer distal resection margin. Ta TME is thus feasible in expert hands, but the learning curve and safety profile are not well defined. Longterm follow-up regarding anal function and oncological outcomes should be performed in the future. | Albert M Wolthuis Gabriele Bislenghi Anthony de Buck van Overstraeten André D'Hoore | 2015 | World Journal of Gastroenterology2015，21，44： | 9 |
| 3 | Surgery for Crohn's disease in the era of biologicals:A reduced need or delayed verdict?显示文摘Crohn's disease(CD) is a chronic inflammatory bowel disease that can affect the entire gastrointestinal tract.Ultimately,up to 70% of all patients will need surgery,despite optimized medical therapy.Moreover,about half of the patients will need redo-surgery because of disease recurrence.The introduction of anti-tumor necrosis factor(TNF) drugs(Infliximab in 1998) revolutionized the treatment of CD.Different randomized trials assessed the efficacy of anti-TNF treatment not only to induce,but also to maintain,steroid-free remission.Furthermore,these agents can rapidly lead to mucosal healing.This aspect is important,as it is a major predictor for long-term disease control.Subgroup analyses of responding patients seemed to suggest a reduction in the need for surgery at median-term follow up(1-3 years).However if one looks at population surveys,one does not observe any decline in the need for surgery since the introduction of Infliximab in 1998.The short follow-up term and the exclusion of patients with imminent surgical need in the randomized trials could bias the results.Only 60% of patients respond to induction of anti-TNF therapy,moreover,some patients will actually develop resistance to biologicals.Many patients are diagnosed when stenosing disease has already occurred,obviating the need for biological therapy.In a further attempt to change the actual course of the disease,top down strategies have been progressively implemented.Whether this will indeed obviate surgery for a substantial group of patients remains unclear.For the time being,surgery will still play a pivotal role in the treatment of CD. | Anthony de Buck van Overstraeten Albert Wolthuis André D'Hoore | 2012 | World Journal of Gastroenterology2012，18，29： | 4 |
| 4 | Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management显示文摘 | Axel Dignass James O. Lindsay Andreas Sturm Alastair Windsor Jean-Frederic Colombel Mathieu Allez Gert D’Haens André D’Hoore Gerassimos Mantzaris Gottfried Novacek Tom ?resland Walter Reinisch Miquel Sans Eduard Stange Severine Vermeire Simon Travis Gert | 2012 | Journal of Crohn’s and Colitis2012，，10： | 4 |
| 5 | STARR with CONTOUR? TRANSTAR? device for obstructed defecation syndrome: one-year real-world outcomes of the European TRANSTAR registry显示文摘 | G. Ribaric A. D’Hoore G. Schiffhorst E. Hempel | 2014 | International Journal of Colorectal Disease2014，，5： | 3 |
| 6 | The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery显示文摘 | K. S?ndenaa P. Quirke W. Hohenberger K. Sugihara H. Kobayashi H. Kessler G. Brown V. Tudyka A. D’Hoore R. H. Kennedy N. P. West S. H. Kim R. Heald K. E. Storli A. Nesbakken B. Moran | 2014 | International Journal of Colorectal Disease2014，，4： | 3 |
| 7 | The Treatment of Peritoneal Carcinomatosis of Colorectal Cancer with Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) with Oxaliplatin: A Belgian Multicentre Prospective Phase II Clinical Study显示文摘 | Daphne Hompes André D’Hoore Eric Cutsem Steffen Fieuws Wim Ceelen Marc Peeters Kurt Speeten Claude Bertrand Hugues Legendre Joseph Kerger | 2012 | Annals of Surgical Oncology2012，，7： | 3 |
| 8 | The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: Current management显示文摘 | A. Dignass G. Van Assche J.O. Lindsay M. Lémann J. S?derholm J.F. Colombel S. Danese A. D’Hoore M. Gassull F. Gomollón D.W. Hommes P. Michetti C. O’Morain T. ?resland A. Windsor E.F. Stange S.P.L. Travis | 2010 | Journal of Crohn’s and Colitis2010，，1： | 2 |
| 9 | The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: A comparative study显示文摘 | D. Hompes A. D’Hoore A. Wolthuis S. Fieuws B. Mirck S. Bruin V. Verwaal | 2014 | J. Surg. Oncol2014，，： | 2 |
| 10 | Rectal washout with cytotoxic solution can be extended to the whole colon显示文摘 | P. P.Mariani J. F.van Pelt N.Ectors B.Topal A.D’Hoore F.Penninckx | 2002 | Br J Surg2002，，12： | 2 |
| 11 | Consensus on ventral rectopexy: report of a panel of experts显示文摘 | M. A. Mercer‐Jones A. D’Hoore A. R. Dixon P. Lehur I. Lindsey A. Mellgren A. R. L. Stevenson | 2014 | Colorectal Dis2014，，2： | 2 |
| 12 | Treatment of small-bowel fistulae in the open abdomen with topical negative-pressure therapy显示文摘 | Mathieu D’Hondt Dirk Devriendt Frank Van Rooy Franky Vansteenkiste André D’Hoore Freddy Penninckx Marc Miserez | 2011 | The American Journal of Surgery2011，，： | 2 |
| 13 | AirSeal system insufflator to maintain a stable pneumorectum during TAMIS显示文摘 | G. Bislenghi A. M. Wolthuis A. Buck van Overstraeten A. D’Hoore | 2015 | Techniques in Coloproctology2015，，1： | 2 |
| 14 | Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: A randomized, double-blind, placebo-controlled trial显示文摘 | Paul Rutgeerts Gert van Assche Séverine Vermeire Geert D’Haens Filip Baert Maja Noman Isolde Aerden Gert de Hertogh Karel Geboes Martin Hiele Andre D’Hoore Freddy Penninckx | 2005 | Gastroenterology2005，，4： | 2 |
| 15 | Peritoneal fluid cytokines and matrix metalloproteinases as early markers of anastomotic leakage in colorectal anastomosis: a literature review and meta‐analysis显示文摘 | C. Cini A. Wolthuis A. D’Hoore | 2013 | Colorectal Dis2013，，9： | 2 |
| 16 | The prognostic value of trail and its death receptors in cervical cancer显示文摘 | Maduro JH Noordhuis MG Ten Hoor KA | 2009 | Int J Rad Oncol Biol Phys2009，75，1： | 1 |
| 17 | Mortality risk analysis following routine vs selective defunctioning stoma formation after total mesorectal excision for rectal cancer显示文摘 | Pata G D'Hoore A Fieuws S | 2009 | Colorectal Dis2009，11，8： | 1 |
| 18 | Patient empowerment in theory and practice: Polysemy or cacophony?显示文摘 | Isabelle Aujoulat William d’Hoore Alain Deccache | 2006 | Patient Education and Counseling2006，，1： | 1 |
| 19 | Long-term outcome of laparoscopic ventral rectopexy for total rectal prolapse显示文摘 | D'Hoore A Cadoni R Penninckx F | 2004 | Br J Surg2004，91，5： | 1 |
| 20 | Leadership, organizational stross and emotional exhaustion among hospital nursing staff 显示文摘 | Stordeur SD Hoore W Vandenberghe C | 2001 | J Adv Nurs2001，35，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员